ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!Qiagen N.V. (QGEN) stock surged +0.95%, trading at $38.94 on NYSE, up from the previous close of $38.57. The stock opened at $39.17, fluctuating between $38.85 and $39.46 in the recent session.
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
Employees | 5700 |
Beta | 0.36 |
Sales or Revenue | $1.97B |
5Y Sales Change% | 0.333% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Diagnostics & Research |
Qiagen N.V. (NYSE: QGEN) stock price is $38.94 in the last trading session. During the trading session, QGEN stock reached the peak price of $39.46 while $38.85 was the lowest point it dropped to. The percentage change in QGEN stock occurred in the recent session was 0.95% while the dollar amount for the price change in QGEN stock was $0.37.
The NYSE listed QGEN is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Qiagen N.V. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Jonathan G. Sheldon Ph.D.
Senior Vice President of Qiagen Digital Insights Bus. Area
Dr. Roland Sackers
Chief Financial Officer, MD & Member of Management Board
Mr. Thierry Bernard
Chief Executive Officer, MD & Member of Management Board
Mr. Thomas Neidert
Vice President of Global Treasury
Mr. John Gilardi
Vice President of Corporation Communications & Investor Relations
Ms. Stephany Foster
Senior Vice President & Head of HR
Dr. Thomas Theuringer
Senior Director & Head of External Communications
Mr. Jean-Pascal Viola
Senior Vice President & Head of Molecular Diagnostics Bus. Area
Mr. Antonio Santos
Senior Vice President & Head of Global Operations
Dr. Thomas Schweins
Senior Vice President of Life Science Bus. Area
QGEN's closing price is 0.21% higher than its 52-week low of $38.49 where as its distance from 52-week high of $47.93 is -19.53%.
Number of QGEN employees currently stands at 5,700.
Official Website of QGEN is: https://www.qiagen.com
QGEN could be contacted at phone 317 735 56600 and can also be accessed through its website. QGEN operates from Hulsterweg 82, Venlo, 5912 PL, Netherlands.
QGEN stock volume for the day was 319.54K shares. The average number of QGEN shares traded daily for last 3 months was 1.07M.
The market value of QGEN currently stands at $8.48B with its latest stock price at $38.94 and 217.68M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com